- Active investigation phase in the EU, Canada, China, Japan and India
- Forming four new wholly owned subsidiaries
- Seeks to acquire an equitable tax treatment
Cannabinoids are poorly absorbed by the body’s gastrointestinal tract, a trait that Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) lipophilic enhancement technology DehydraTECH™ is changing. Previously, consumers have turned to cannabis smoking to achieve higher effectiveness. However, human clinical studies have shown DehydraTECH™ to have a quick rate of absorption, allowing users to avoid the risks associated with smoking. DehydraTECH™ offers improved taste and smell, with effects felt within 15 to 20 minutes as opposed to the 60-120 minutes associated with traditional ingestion methods. This edible technology is patent-protected for CBD and all other cannabinoids, with the potential to revolutionize additional industries.
Lexaria is a biotechnology company that out-licenses its disruptive delivery technology promoting healthier ingestion methods. The company is the only one worldwide that has…
More from NetworkNewsWire
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information please visit https://www.NetworkNewsWire.
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com